Mainstream

Omeros signals debt reduction of over $100M and prioritizes narsoplimab launch following FDA BLA acceptance

Omeros signals debt reduction of over $100M and prioritizes narsoplimab launch following FDA BLA acceptance

Post ContentomerRead More

You might also be interested in reading Chainlink (LINK) Breaks Out Of Range; Will Bulls Push The Price To $12?.

May 16, 2025
In Mainstream